Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial...

Por Gauthier, Serge, Feldman, Howard H, Schneider, Lon S, Wilcock, Gordon K, Frisoni, Giovanni B, Hardlund, Jiri H, Moebius, Hans J, Bentham, Peter, Kook, Karin A, Wischik, Damon J, Schelter, Bjoern O, Davis, Charles S, Staff, Roger T, Bracoud, Luc, Shamsi, Kohkan, Storey, John M D, Harrington, Charles R, Wischik, Claude M
Publicado no Lancet (2016)

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome i...

Por Wilcock, Gordon K., Gauthier, Serge, Frisoni, Giovanni B., Jia, Jianping, Hardlund, Jiri H., Moebius, Hans J., Bentham, Peter, Kook, Karin A., Schelter, Bjoern O., Wischik, Damon J., Davis, Charles S., Staff, Roger T., Vuksanovic, Vesna, Ahearn, Trevor, Bracoud, Luc, Shamsi, Kohkan, Marek, Ken, Seibyl, John, Riedel, Gernot, Storey, John M.D., Harrington, Charles R., Wischik, Claude M.
Publicado no J Alzheimers Dis (2017)